Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Sell
14,520
-530
-4% -$61.2K 0.08% 82
2026
Q1
$1.8M Sell
15,050
-8,100
-35% -$1.06M 0.1% 69
2025
Q4
$3.15M Hold
23,150
0.18% 62
2025
Q3
$3.41M Sell
23,150
-64,350
-74% -$8.92M 0.23% 61
2025
Q2
$11.3M Sell
87,500
-8,500
-9% -$1.03M 0.86% 33
2025
Q1
$11.5M Buy
96,000
+4,500
+5% +$558K 0.95% 28
2024
Q4
$10.6M Buy
91,500
+26,500
+41% +$3.35M 0.83% 34
2024
Q3
$8.78M Hold
65,000
0.75% 45
2024
Q2
$8.82M Buy
+65,000
New +$8.84M 0.76% 45

Other funds holding XYL

DNCA Finance's XYL Position: Q2 2026 in Review

DNCA Finance reduced its Xylem (XYL) stake by 3.5% in Q2 2026, selling an estimated $61.2K and leaving 14,520 shares worth $1.72M. The position accounts for 0.08% of the portfolio, ranked #82.

DNCA Finance first reported a position in XYL in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.5M in Q1 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • DNCA Finance held 14,520 shares of Xylem worth $1.72M as of Q2 2026.
  • DNCA Finance sold 530 Xylem shares in Q2 2026, an estimated $61.2K.
  • Xylem made up 0.08% of DNCA Finance's portfolio in Q2 2026, its #82 holding.
  • DNCA Finance first reported a position in Xylem in Q2 2024 and has held it in 9 quarters since.
  • DNCA Finance's Xylem position peaked at $11.5M in Q1 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on DNCA Finance's 13F filing for Q2 2026, filed 13 Aug 2026.